Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 52 results.
User Information
Export Records
  1. 1.   Sodium Fluoride-18 and Radium-223 Dichloride Uptake Colocalize in Osteoblastic Mouse Xenograft Tumors
  2. Phelps, Tim E.; Roy, Jyoti; Green, Michael V.; Seidel,Jurgen; Baidoo, Kwamena E.; Adler,Stephen; Edmondson,Elijah; Butcher,Donna; Matta,Jennifer; Ton, Anita T.; Wong, Karen; Huang, Shan; Ren, Ling; LeBlanc, Amy K.; Choyke, Peter L.; Jagoda, Elaine M.
  3. Cancer biotherapy & radiopharmaceuticals. 2021, Mar; 36(2): 133-142.
  1. 2.   Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
  2. Xie, Yingda L.; de Jager, Veronique R.; Chen, Ray Y.; Dodd, Lori E.; Paripati, Praveen; Via, Laura E.; Follmann, Dean; Wang,Jing; Lumbard, Keith; Lahouar, Saher; Malherbe, Stephanus T.; Andrews, Jenna; Yu, Xiang; Goldfeder, Lisa C.; Cai, Ying; Arora, Kriti; Loxton, Andre G.; Vanker, Naadira; Duvenhage,Michael; Winter, Jill; Song, Taeksun; Walzl, Gerhard; Diacon, Andreas H.; Barry, Clifton E.
  3. Science Translational Medicine. 2021, Feb 3; 13(579):
  1. 3.   Galectin-3 Involvement in Fibrotic Diseases
  2. Jiang, Xiaosong; Torok, Natalie J.; Barchi,Joe
  3. ANTI-FIBROTIC DRUG DISCOVERY. 2020; 73 : 185-210.
  1. 4.   Alterations of T-cell surface markers in older women with persistent human papillomavirus infection
  2. Rodriguez, A. C.; Garcia-Pineres, A. J.; Hildesheim, A.; Herrero, R.; Trivett, M.; Williams, M.; Atmella, I.; Ramirez, M.; Villegas, M.; Schiffman, M.; Burk, R.; Freer, E.; Bonilla, J.; Bratti, C.; Pinto, L. A.
  3. International Journal of Cancer. 2011, Feb; 128(3): 597-607.
  1. 5.   Tumors induce complex DNA damage in distant proliferative tissues in vivo
  2. Redon, C. E.; Dickey, J. S.; Nakamura, A. J.; Kareva, I. G.; Naf, D.; Nowsheen, S.; Kryston, T. B.; Bonner, W. M.; Georgakilas, A. G.; Sedelnikova, O. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Oct; 107(42): 17992-17997.
  1. 6.   Transplacental arsenic carcinogenesis in mice
  2. Waalkes, M. P.; Liu, J.; Diwan, B. A.
  3. Toxicology and Applied Pharmacology. 2007, Aug; 222(3): 271-280.
  1. 7.   Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide
  2. Chen, K. Q.; Iribarren, P.; Hu, J. Y.; Chen, J. H.; Gong, W. H.; Cho, E. H.; Lockett, S.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Biological Chemistry. 2006, FEB 10; 281(6): 3651-3659.
  1. 8.   Examining Ty3 polypurine tract structure and function by nucleoside analog interference
  2. Dash, C.; Marino, J. P.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2006, FEB 3; 281(5): 2773-2783.
  1. 9.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 10.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 11.   Inhibition of pathologic retinal neovascularization by alpha-defensins
  2. Economopoulou, M.; Bdeir, K.; Cines, D. B.; Fogt, F.; Bdeir, Y.; Lubkowski, J.; Lu, W. Y.; Preissner, K. T.; Hammes, H. P.; Chavakis, T.
  3. Blood. 2005, DEC 1; 106(12): 3831-3838.
  1. 12.   Carbohydrate array analysis of anti-Tn antibodies and lectins reveals unexpected specificities: Implications for diagnostic and vaccine development
  2. Manimala, J. C.; Li, Z. T.; Jain, A.; VedBrat, S.; Gildersleeve, J. C.
  3. Chembiochem. 2005, DEC; 6(12): 2229-2241.
  1. 13.   Persistent amyloidosis following suppression of A beta production in a transgenic model of Alzheimer disease
  2. Jankowsky, J. L.; Slunt, H. H.; Gonzales, V.; Savonenko, A. V.; Wen, J. C.; Jenkins, N. A.; Copeland, N. G.; Younkin, L. H.; Lester, H. A.; Younkin, S. G.; Borchelt, D. R.
  3. Plos Medicine. 2005, DEC; 2(12): 1318-1333.
  1. 14.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 15.   Human leukocyte antigen class I and II haplotypes and risk of cervical cancer
  2. Carreon, J. D.; Martin, M. P.; Hildesheim, A.; Gao, X.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Zaino, R. J.; Carrington, M.; Wang, S. S.
  3. Tissue Antigens. 2005, OCT; 66(4): 321-324.
  1. 16.   High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors
  2. Vocke, C. D.; Yang, Y. F.; Pavlovich, C. P.; Schmidt, L. S.; Nickerson, M. L.; Torres-Cabala, C. A.; Merino, M. J.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. Journal of the National Cancer Institute. 2005, JUN 15; 97(12): 931-935.
  1. 17.   CYP1A1 Val(462) and NQO1 Ser(187) polymorphisms, cigarette use, and risk for colorectal adenoma
  2. Hou, L. F.; Chatterjee, N.; Huang, W. Y.; Baccarelli, A.; Yadavalli, S.; Yeager, M.; Bresalier, R. S.; Chanock, S. J.; Caporaso, N. E.; Ji, B. T.; Weissfeld, J. L.; Hayes, R. B.
  3. Carcinogenesis. 2005, JUN; 26(6): 1122-1128.
  1. 18.   Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
  2. Brouwers, F. M.; Petricoin, E. F.; Ksinantova, L.; Breza, J.; Rajapakse, V.; Ross, S.; Johann, D.; Mannelli, M.; Shulkin, B. L.; Kvetnansky, R.; Eisenhofer, G.; Walther, M. M.; Hitt, B. A.; Conrads, T. P.; Veenstra, T. D.; Mannion, D. P.; Wall, M. R.; Wolfe, G. M.; Fusaro, V. A.; Liotta, L. A.; Pacak, K.
  3. Endocrine-Related Cancer. 2005, JUN; 12(2): 263-272.
  1. 19.   Investigating HIV-1 polypurine tract geometry via targeted insertion of abasic lesions in the (-)-DNA template and (+)-RNA primer
  2. Yi-Brunozzi, H. Y.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2005, MAY 20; 280(20): 20154-20162.
  1. 20.   Activation of discoidin domain receptor 1 on CD14-positive pronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
  2. Matsuyama, W.; Watanabe, M.; Shirahama, Y.; Oonakahara, K. I.; Higashimoto, I.; Yoshimura, T.; Osame, M.; Arimura, K.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6490-6498.
  1. 21.   A bifunctional DNA repair protein from Ferroplasma acidarmanus exhibits O-6-alkylguanine-DNA alkyltransferase and endonuclease V activities
  2. Kanugula, S.; Pauly, G. T.; Moschel, R. C.; Pegg, A. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, MAR 8; 102(10): 3617-3622.
  1. 22.   Birt-Hogg-Dube syndrome, a genodermatosis that increases risk for renal carcinoma
  2. Schmidt, L. S.
  3. Current Molecular Medicine. 2004, DEC; 4(8): 877-885.
  1. 23.   Angiogenesis as an immunopharmacologic target in inflammation and cancer
  2. Bian, X. W.; Chen, J. H.; Jiang, X. F.; Bai, J. S.; Wang, Q. L.; Zhang, X.
  3. International Immunopharmacology. 2004, NOV; 4(12): 1537-1547.
  1. 24.   Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: Role of inclusion body formation
  2. Waalkes, M. P.; Liu, J.; Goyer, R. A.; Diwan, B. A.
  3. Cancer Research. 2004, NOV 1; 64(21): 7766-7772.
  1. 25.   The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay
  2. Donovan, P. J.; Smith, G. T.; Nardone, R.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, OCT 4; 554(1-2): 111-120.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel